Bristol-Myers Squibb Company (NYSE:BMY) 43rd Annual J.P. Morgan Healthcare Conference January 13, 2024 10:30 AM ET
Company Participants
Chris Boerner – Chairman and Chief Executive Officer
Conference Call Participants
Chris Schott – JPMorgan
Chris Schott
Good morning everybody. I’m Chris Schott at J.P. Morgan, and it’s great to see everyone again. It’s my pleasure today to be introducing Bristol-Myers, who is again kicking off the J.P. Morgan Healthcare Conference.
From the company, we have the company’s Chairman and CEO, Chris Boerner. So Chris, Happy New Year. Thanks for joining us and looking forward to the presentation.
Chris Boerner
Thank you, Chris. Good morning and Happy New Year to everyone. It’s great to be kicking off another J.P. Morgan this year and I am looking forward to a very good discussion this morning and throughout the day.
It has been an action packed first year for me as CEO of Bristol-Myers Squibb. I am incredibly proud of what we accomplished last year and today what I want to do is give you an update on where we are in our journey and the path that we’re charting to deliver for patients and for shareholders.
So obviously today we’ll be making some forward-looking statements and here are my disclosures. So let me start by saying that last year at this conference we laid out a roadmap for the multi-year journey that we’re on to reshape BMS with the overarching goal to deliver sustained top tier growth and drive long-term shareholder value. We aim in fact to be one of the fastest growing companies in the sector by the end of the decade. And we are now one year in and I think one year closer to achieving that objective.
And so what I want to do today is I want to give
Read the full article here